BSPK
Price
$0.14
Change
-$0.06 (-30.00%)
Updated
Aug 7 closing price
Capitalization
1.56M
OVATF
Price
$0.04
Change
-$0.01 (-20.00%)
Updated
Jul 3 closing price
Capitalization
1.28M
Interact to see
Advertisement

BSPK vs OVATF

Header iconBSPK vs OVATF Comparison
Open Charts BSPK vs OVATFBanner chart's image
Bespoke Extracts
Price$0.14
Change-$0.06 (-30.00%)
Volume$26.11K
Capitalization1.56M
Ovation Science
Price$0.04
Change-$0.01 (-20.00%)
Volume$10K
Capitalization1.28M
BSPK vs OVATF Comparison Chart in %
Loading...
BSPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OVATF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSPK vs. OVATF commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSPK is a Hold and OVATF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (BSPK: $0.14 vs. OVATF: $0.04)
Brand notoriety: BSPK and OVATF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BSPK: 63% vs. OVATF: 119%
Market capitalization -- BSPK: $1.56M vs. OVATF: $1.28M
BSPK [@Pharmaceuticals: Generic] is valued at $1.56M. OVATF’s [@Pharmaceuticals: Generic] market capitalization is $1.28M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.3B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSPK’s FA Score shows that 0 FA rating(s) are green whileOVATF’s FA Score has 0 green FA rating(s).

  • BSPK’s FA Score: 0 green, 5 red.
  • OVATF’s FA Score: 0 green, 5 red.
According to our system of comparison, OVATF is a better buy in the long-term than BSPK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSPK’s TA Score shows that 3 TA indicator(s) are bullish while OVATF’s TA Score has 2 bullish TA indicator(s).

  • BSPK’s TA Score: 3 bullish, 4 bearish.
  • OVATF’s TA Score: 2 bullish, 1 bearish.
According to our system of comparison, OVATF is a better buy in the short-term than BSPK.

Price Growth

BSPK (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while OVATF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +6.26%. For the same industry, the average monthly price growth was +68.76%, and the average quarterly price growth was +80.82%.

Industries' Descriptions

@Pharmaceuticals: Generic (+6.26% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSPK($1.56M) has a higher market cap than OVATF($1.28M). BSPK YTD gains are higher at: 130.263 vs. OVATF (4.500). OVATF has higher annual earnings (EBITDA): -339.46K vs. BSPK (-1M). BSPK has more cash in the bank: 21.4K vs. OVATF (10.2K). OVATF has less debt than BSPK: OVATF (284K) vs BSPK (1.16M). BSPK has higher revenues than OVATF: BSPK (1.08M) vs OVATF (90.3K).
BSPKOVATFBSPK / OVATF
Capitalization1.56M1.28M122%
EBITDA-1M-339.46K296%
Gain YTD130.2634.5002,895%
P/E RatioN/AN/A-
Revenue1.08M90.3K1,196%
Total Cash21.4K10.2K210%
Total Debt1.16M284K408%
FUNDAMENTALS RATINGS
BSPK vs OVATF: Fundamental Ratings
BSPK
OVATF
OUTLOOK RATING
1..100
8940
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
64
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4644
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OVATF's Valuation (64) in the null industry is in the same range as BSPK (95). This means that OVATF’s stock grew similarly to BSPK’s over the last 12 months.

OVATF's Profit vs Risk Rating (100) in the null industry is in the same range as BSPK (100). This means that OVATF’s stock grew similarly to BSPK’s over the last 12 months.

OVATF's SMR Rating (100) in the null industry is in the same range as BSPK (100). This means that OVATF’s stock grew similarly to BSPK’s over the last 12 months.

OVATF's Price Growth Rating (44) in the null industry is in the same range as BSPK (46). This means that OVATF’s stock grew similarly to BSPK’s over the last 12 months.

OVATF's P/E Growth Rating (100) in the null industry is in the same range as BSPK (100). This means that OVATF’s stock grew similarly to BSPK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSPKOVATF
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
34%
MACD
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
53%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
45%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
36%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BSPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OVATF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABTS4.210.09
+2.22%
Abits Group Inc
FATE1.090.02
+1.87%
Fate Therapeutics
GCI4.23-0.02
-0.47%
Gannett Co
EIX55.50-0.52
-0.93%
Edison International
WSBC30.67-0.63
-2.01%
WesBanco

BSPK and

Correlation & Price change

A.I.dvisor tells us that BSPK and OVATF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSPK and OVATF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSPK
1D Price
Change %
BSPK100%
N/A
OVATF - BSPK
21%
Poorly correlated
N/A
BKUH - BSPK
8%
Poorly correlated
N/A
AVCNF - BSPK
5%
Poorly correlated
-2.28%
CANN - BSPK
4%
Poorly correlated
-9.82%
CAIHF - BSPK
2%
Poorly correlated
N/A
More

OVATF and

Correlation & Price change

A.I.dvisor tells us that OVATF and KHTRF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OVATF and KHTRF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OVATF
1D Price
Change %
OVATF100%
N/A
KHTRF - OVATF
25%
Poorly correlated
N/A
KKPCF - OVATF
24%
Poorly correlated
N/A
BSPK - OVATF
20%
Poorly correlated
N/A
NPPNY - OVATF
9%
Poorly correlated
N/A
PCLOF - OVATF
5%
Poorly correlated
-23.05%
More